title: Treatment of posttransplant erythrocytosis with losartan.
authors.affiliation: Department of Nephrology and Renal Transplantation, Hopital Saint Jacques, Besançon, France.
authors.forename: D
authors.initials: D
authors.lastname: Ducloux
authors.forename: V
authors.initials: V
authors.lastname: Fournier
authors.forename: C
authors.initials: C
authors.lastname: Bresson-Vautrin
authors.forename: J M
authors.initials: JM
authors.lastname: Chalopin
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001713:Biphenyl Compounds / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000009:adverse effects*; D019808:Losartan; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000188:drug therapy* / Q000209:etiology; D013777:Tetrazoles / Q000008:administration & dosage*
chemical_list: D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D019808:Losartan